Inspire Medical Systems, Inc. (INSP)

Market Cap	1.26B -72.6%
Revenue (ttm)	915.25M +8.9%
Net Income	131.14M +97.2%
EPS	4.47 +106.4%
Shares Out	28.81M
PE Ratio	9.80
Forward PE	43.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	935,019
Open	42.89
Previous Close	44.74
Day's Range	42.60 - 44.26
52-Week Range	39.61 - 148.55
Beta	0.83
Analysts	Hold
Price Target	53.33 (+21.7%)
Earnings Date	May 4, 2026

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open ai...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 1,333
• Stock Exchange: NYSE
• Ticker Symbol: INSP
• Website: https://www.inspiresleep.com

Financial Performance

In 2025, Inspire Medical Systems's revenue was $911.98 million, an increase of 13.60% compared to the previous year's $802.80 million. Earnings were $145.42 million, an increase of 171.77%.

Analyst Summary

According to 15 analysts, the average rating for INSP stock is "Hold." The 12-month stock price target is $53.33, which is an increase of 21.70% from the latest price.

Price Target

$53.33

(21.70% upside)

Analyst Consensus: Hold